In this study, we found that Abrine as an IDO1 inhibitor has an inhibition effect on immune escape, and its combination therapy with immune checkpoint inhibitor anti-PD-1 antibody exerted a better anti-tumor effect. The gene discussed is PDCD1; the disease is neoplasm.